244 related articles for article (PubMed ID: 26844379)
1. Adaptation within mitochondrial oxidative phosphorylation supercomplexes and membrane viscosity during degeneration of dopaminergic neurons in an animal model of early Parkinson's disease.
Kuter K; Kratochwil M; Berghauzen-Maciejewska K; Głowacka U; Sugawa MD; Ossowska K; Dencher NA
Biochim Biophys Acta; 2016 Apr; 1862(4):741-753. PubMed ID: 26844379
[TBL] [Abstract][Full Text] [Related]
2. Increased energetic demand supported by mitochondrial electron transfer chain and astrocyte assistance is essential to maintain the compensatory ability of the dopaminergic neurons in an animal model of early Parkinson's disease.
Kuter KZ; Olech Ł; Dencher NA
Mitochondrion; 2019 Jul; 47():227-237. PubMed ID: 30578987
[TBL] [Abstract][Full Text] [Related]
3. Native DIGE proteomic analysis of mitochondria from substantia nigra and striatum during neuronal degeneration and its compensation in an animal model of early Parkinson's disease.
Kuter K; Kratochwil M; Marx SH; Hartwig S; Lehr S; Sugawa MD; Dencher NA
Arch Physiol Biochem; 2016 Dec; 122(5):238-256. PubMed ID: 27467289
[TBL] [Abstract][Full Text] [Related]
4. Prolonged Dysfunction of Astrocytes and Activation of Microglia Accelerate Degeneration of Dopaminergic Neurons in the Rat Substantia Nigra and Block Compensation of Early Motor Dysfunction Induced by 6-OHDA.
Kuter K; Olech Ł; Głowacka U
Mol Neurobiol; 2018 Apr; 55(4):3049-3066. PubMed ID: 28466266
[TBL] [Abstract][Full Text] [Related]
5. Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.
Perfeito R; Cunha-Oliveira T; Rego AC
Free Radic Biol Med; 2013 Sep; 62():186-201. PubMed ID: 23743292
[TBL] [Abstract][Full Text] [Related]
6. Hesperidin protects against behavioral alterations and loss of dopaminergic neurons in 6-OHDA-lesioned mice: the role of mitochondrial dysfunction and apoptosis.
Antunes MS; Ladd FVL; Ladd AABL; Moreira AL; Boeira SP; Cattelan Souza L
Metab Brain Dis; 2021 Jan; 36(1):153-167. PubMed ID: 33057922
[TBL] [Abstract][Full Text] [Related]
7. Mfn2 protects dopaminergic neurons exposed to paraquat both in vitro and in vivo: Implications for idiopathic Parkinson's disease.
Zhao F; Wang W; Wang C; Siedlak SL; Fujioka H; Tang B; Zhu X
Biochim Biophys Acta Mol Basis Dis; 2017 Jun; 1863(6):1359-1370. PubMed ID: 28215578
[TBL] [Abstract][Full Text] [Related]
8. Allogeneic/xenogeneic transplantation of peptide-labeled mitochondria in Parkinson's disease: restoration of mitochondria functions and attenuation of 6-hydroxydopamine-induced neurotoxicity.
Chang JC; Wu SL; Liu KH; Chen YH; Chuang CS; Cheng FC; Su HL; Wei YH; Kuo SJ; Liu CS
Transl Res; 2016 Apr; 170():40-56.e3. PubMed ID: 26730494
[TBL] [Abstract][Full Text] [Related]
9. Manganese exposure exacerbates progressive motor deficits and neurodegeneration in the MitoPark mouse model of Parkinson's disease: Relevance to gene and environment interactions in metal neurotoxicity.
Langley MR; Ghaisas S; Ay M; Luo J; Palanisamy BN; Jin H; Anantharam V; Kanthasamy A; Kanthasamy AG
Neurotoxicology; 2018 Jan; 64():240-255. PubMed ID: 28595911
[TBL] [Abstract][Full Text] [Related]
10. Axin-2 knockdown promote mitochondrial biogenesis and dopaminergic neurogenesis by regulating Wnt/β-catenin signaling in rat model of Parkinson's disease.
Singh S; Mishra A; Mohanbhai SJ; Tiwari V; Chaturvedi RK; Khurana S; Shukla S
Free Radic Biol Med; 2018 Dec; 129():73-87. PubMed ID: 30176346
[TBL] [Abstract][Full Text] [Related]
11. Novel Food Supplement "CP1" Improves Motor Deficit, Cognitive Function, and Neurodegeneration in Animal Model of Parkinson's Disease.
Wattanathorn J; Sutalangka C
Rejuvenation Res; 2016 Aug; 19(4):273-85. PubMed ID: 26414358
[TBL] [Abstract][Full Text] [Related]
12. Cholesterol contributes to dopamine-neuronal loss in MPTP mouse model of Parkinson's disease: Involvement of mitochondrial dysfunctions and oxidative stress.
Paul R; Choudhury A; Kumar S; Giri A; Sandhir R; Borah A
PLoS One; 2017; 12(2):e0171285. PubMed ID: 28170429
[TBL] [Abstract][Full Text] [Related]
13. Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms.
Perier C; Bender A; García-Arumí E; Melià MJ; Bové J; Laub C; Klopstock T; Elstner M; Mounsey RB; Teismann P; Prolla T; Andreu AL; Vila M
Brain; 2013 Aug; 136(Pt 8):2369-78. PubMed ID: 23884809
[TBL] [Abstract][Full Text] [Related]
14. Lack of Parkin Anticipates the Phenotype and Affects Mitochondrial Morphology and mtDNA Levels in a Mouse Model of Parkinson's Disease.
Pinto M; Nissanka N; Moraes CT
J Neurosci; 2018 Jan; 38(4):1042-1053. PubMed ID: 29222404
[No Abstract] [Full Text] [Related]
15. [Estrogen protects the dopaminergic neurons in substantia nigra against damage induced by 6-hydroxydopamine].
Meng JL; Ma YY; Luo HY; Kong SZ; He YW; Dong BC; Wu SH; He M
Sheng Li Xue Bao; 2008 Jun; 60(3):369-74. PubMed ID: 18560728
[TBL] [Abstract][Full Text] [Related]
16. Voltage-dependent anion channel involved in the α-synuclein-induced dopaminergic neuron toxicity in rats.
Lu L; Zhang C; Cai Q; Lu Q; Duan C; Zhu Y; Yang H
Acta Biochim Biophys Sin (Shanghai); 2013 Mar; 45(3):170-8. PubMed ID: 23291291
[TBL] [Abstract][Full Text] [Related]
17. Protective effects of β- nicotinamide adenine dinucleotide against motor deficits and dopaminergic neuronal damage in a mouse model of Parkinson's disease.
Shan C; Gong YL; Zhuang QQ; Hou YF; Wang SM; Zhu Q; Huang GR; Tao B; Sun LH; Zhao HY; Li ST; Liu JM
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Aug; 94():109670. PubMed ID: 31220519
[TBL] [Abstract][Full Text] [Related]
18. 6-OHDA Induces Oxidation of F-box Protein Fbw7β by Chaperone-Mediated Autophagy in Parkinson's Model.
Wang X; Zhai H; Wang F
Mol Neurobiol; 2018 Jun; 55(6):4825-4833. PubMed ID: 28733899
[TBL] [Abstract][Full Text] [Related]
19. A Nurr1 agonist causes neuroprotection in a Parkinson's disease lesion model primed with the toll-like receptor 3 dsRNA inflammatory stimulant poly(I:C).
Smith GA; Rocha EM; Rooney T; Barneoud P; McLean JR; Beagan J; Osborn T; Coimbra M; Luo Y; Hallett PJ; Isacson O
PLoS One; 2015; 10(3):e0121072. PubMed ID: 25815475
[TBL] [Abstract][Full Text] [Related]
20. NOD2 promotes dopaminergic degeneration regulated by NADPH oxidase 2 in 6-hydroxydopamine model of Parkinson's disease.
Cheng L; Chen L; Wei X; Wang Y; Ren Z; Zeng S; Zhang X; Wen H; Gao C; Liu H
J Neuroinflammation; 2018 Aug; 15(1):243. PubMed ID: 30157869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
